Tomas Bjerner
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Tomas Bjerner has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
Gerhard Wikström
4 shared publicationsHåkan Ahlström
4 shared publicationsLars Johansson
4 shared publicationsAnders Ericsson
3 shared publications- Bertil Lindahl
Department of Medical Sciences Uppsala University Uppsala Sweden
3 shared publications - Håkan Ahlström
Radiology, Department of Surgical Sciences, Uppsala University, Uppsala, SE-75185, Sweden
3 shared publications
Latest Publications
- Open Access
- 1 January 2016
- Published by Elsevier in Journal of Cardiovascular Magnetic Resonance
- Vol. 18 (1) , 43-6
Long-term prognosis of unrecognized myocardial infarction detected with cardiovascular magnetic resonance in an elderly population
- 1 January 2016
- Published by Elsevier in Journal of Cardiovascular Magnetic Resonance
- Vol. 18 (1) , 43-6
Open AccessLong-term prognosis of unrecognized myocardial infarction detected with cardiovascular magnetic resonance in an elderly population
- Open Access
- 26 October 2015
- Published by Springer Nature in EJNMMI Physics
- Vol. 2 (1) , 1-13
Automatic extraction of forward stroke volume using dynamic PET/CT: a dual-tracer and dual-scanner validation in patients with heart valve disease
The aim of this study was to develop and validate an automated method for extracting forward stroke volume (FSV) using indicator dilution theory directly from dynamic positron emission tomography (PET) studies for two different tracers and scanners. 35 subjects underwent a dynamic 11C-acetate PET scan on a Siemens Biograph TruePoint-64 PET/CT (scanner I). In addition, 10 subjects underwent both dynamic 15O-water PET and 11C-acetate PET scans on a GE Discovery-ST PET/CT (scanner II). The left ventricular (LV)-aortic time-activity curve (TAC) was extracted automatically from PET data using cluster analysis. The first-pass peak was isolated by automatic extrapolation of the downslope of the TAC. FSV was calculated as the injected dose divided by the product of heart rate and the area under the curve of the first-pass peak. Gold standard FSV was measured using phase-contrast cardiovascular magnetic resonance (CMR). FSVPET correlated highly with FSVCMR (r = 0.87, slope = 0.90 for scanner I, r = 0.87, slope = 1.65, and r = 0.85, slope = 1.69 for scanner II for 15O-water and 11C-acetate, respectively) although a systematic bias was observed for both scanners (p < 0.001 for all). FSV based on 11C-acetate and 15O-water correlated highly (r = 0.99, slope = 1.03) with no significant difference between FSV estimates (p = 0.14). FSV can be obtained automatically using dynamic PET/CT and cluster analysis. Results are almost identical for 11C-acetate and 15O-water. A scanner-dependent bias was observed, and a scanner calibration factor is required for multi-scanner studies. Generalization of the method to other tracers and scanners requires further validation.
- 26 October 2015
- Published by Springer Nature in EJNMMI Physics
- Vol. 2 (1) , 1-13
Open AccessAutomatic extraction of forward stroke volume using dynamic PET/CT: a dual-tracer and dual-scanner validation in patients with heart valve disease
The aim of this study was to develop and validate an automated method for extracting forward stroke volume (FSV) using indicator dilution theory directly from dynamic positron emission tomography (PET) studies for two different tracers and scanners. 35 subjects underwent a dynamic 11C-acetate PET scan on a Siemens Biograph TruePoint-64 PET/CT (scanner I). In addition, 10 subjects underwent both dynamic 15O-water PET and 11C-acetate PET scans on a GE Discovery-ST PET/CT (scanner II). The left ventricular (LV)-aortic time-activity curve (TAC) was extracted automatically from PET data using cluster analysis. The first-pass peak was isolated by automatic extrapolation of the downslope of the TAC. FSV was calculated as the injected dose divided by the product of heart rate and the area under the curve of the first-pass peak. Gold standard FSV was measured using phase-contrast cardiovascular magnetic resonance (CMR). FSVPET correlated highly with FSVCMR (r = 0.87, slope = 0.90 for scanner I, r = 0.87, slope = 1.65, and r = 0.85, slope = 1.69 for scanner II for 15O-water and 11C-acetate, respectively) although a systematic bias was observed for both scanners (p < 0.001 for all). FSV based on 11C-acetate and 15O-water correlated highly (r = 0.99, slope = 1.03) with no significant difference between FSV estimates (p = 0.14). FSV can be obtained automatically using dynamic PET/CT and cluster analysis. Results are almost identical for 11C-acetate and 15O-water. A scanner-dependent bias was observed, and a scanner calibration factor is required for multi-scanner studies. Generalization of the method to other tracers and scanners requires further validation.
- Open Access
- 1 January 2015
- Published by Elsevier in Journal of Cardiovascular Magnetic Resonance
- Vol. 17 (1) , 98-9
Unrecognized myocardial infarctions assessed by cardiovascular magnetic resonance are associated with the severity of the stenosis in the supplying coronary artery
- 1 January 2015
- Published by Elsevier in Journal of Cardiovascular Magnetic Resonance
- Vol. 17 (1) , 98-9
Open AccessUnrecognized myocardial infarctions assessed by cardiovascular magnetic resonance are associated with the severity of the stenosis in the supplying coronary artery
- 1 May 2012
- Published by Bentham Science Publishers Ltd. in Current Medical Imaging
- Vol. 8 (2) , 76-81
The Clinical Perspective on Value of 3D, Thin Slice T2-Weighted Images in 3T Pelvic MRI for Tumors
Pelvic imaging is undergoing rapid changes due to increased use of 3-Tesla (3T) magnetic resonance imaging (3T MRI). One of the advantages of 3T could be the possibility for thin section 3-dimensional (3D) imaging which could improve accuracy and at the same time reduce the need for multi-planar imaging needed for conventional T2 imaging (TSE). In the following text we review the advantages of 3D thin section imaging for assessment of pelvic tumors.
- 1 May 2012
- Published by Bentham Science Publishers Ltd. in Current Medical Imaging
- Vol. 8 (2) , 76-81
The Clinical Perspective on Value of 3D, Thin Slice T2-Weighted Images in 3T Pelvic MRI for Tumors
Pelvic imaging is undergoing rapid changes due to increased use of 3-Tesla (3T) magnetic resonance imaging (3T MRI). One of the advantages of 3T could be the possibility for thin section 3-dimensional (3D) imaging which could improve accuracy and at the same time reduce the need for multi-planar imaging needed for conventional T2 imaging (TSE). In the following text we review the advantages of 3D thin section imaging for assessment of pelvic tumors.
- Open Access
- 1 December 2004
- Published by Oxford University Press (OUP)
- Vol. 25 (23) , 2171-2172
Quantification of peri-operative myocardial infarction after coronary artery bypass surgery
Finally, we believe that the patchy distribution pattern may have been caused by global ischaemia, resulting in the spread of necrosis. The patchy pattern was p
- 1 December 2004
- Published by Oxford University Press (OUP)
- Vol. 25 (23) , 2171-2172
Open AccessQuantification of peri-operative myocardial infarction after coronary artery bypass surgery
Finally, we believe that the patchy distribution pattern may have been caused by global ischaemia, resulting in the spread of necrosis. The patchy pattern was p
- 1 August 2004
- Published by Wolters Kluwer Health in Investigative Radiology
- Vol. 39 (8) , 479-486
In and Ex Vivo MR Evaluation of Acute Myocardial Ischemia in Pigs by Determining R1 in Steady State After the Administration of the Intravascular Contrast Agent NC100150 Injection
To study the dose response in perfused and nonperfused myocardium by measuring relaxation rate (R1) in a steady-state situation after injection of the intravascular contrast agent NC100150 Injection in pigs and whether the dose response differs in vivo and ex vivo. The left anterior descending artery was occluded. R1 was measured using a Look-Locker sequence for 2 dose groups (2 mg Fe/kg bw, n = 4, and 5 mg Fe/kg bw, n = 5) and a control group (n = 3). A significant increase in R1 was found in perfused myocardium after contrast agent injection, in contrast to nonperfused myocardium. There was a significantly larger difference in R1 between perfused and nonperfused myocardium in the 5 mg Fe/kg bw dose group compared with the other 2 groups. The difference in R1 between perfused and nonperfused myocardium was significantly higher in vivo than ex vivo. A nearly linear R1 dose response was found in perfused myocardium in vivo. The dose response ex vivo was less steep possibly due to larger water exchange limitations.
- 1 August 2004
- Published by Wolters Kluwer Health in Investigative Radiology
- Vol. 39 (8) , 479-486
In and Ex Vivo MR Evaluation of Acute Myocardial Ischemia in Pigs by Determining R1 in Steady State After the Administration of the Intravascular Contrast Agent NC100150 Injection
To study the dose response in perfused and nonperfused myocardium by measuring relaxation rate (R1) in a steady-state situation after injection of the intravascular contrast agent NC100150 Injection in pigs and whether the dose response differs in vivo and ex vivo. The left anterior descending artery was occluded. R1 was measured using a Look-Locker sequence for 2 dose groups (2 mg Fe/kg bw, n = 4, and 5 mg Fe/kg bw, n = 5) and a control group (n = 3). A significant increase in R1 was found in perfused myocardium after contrast agent injection, in contrast to nonperfused myocardium. There was a significantly larger difference in R1 between perfused and nonperfused myocardium in the 5 mg Fe/kg bw dose group compared with the other 2 groups. The difference in R1 between perfused and nonperfused myocardium was significantly higher in vivo than ex vivo. A nearly linear R1 dose response was found in perfused myocardium in vivo. The dose response ex vivo was less steep possibly due to larger water exchange limitations.
- Open Access
- 1 August 2004
- Published by Oxford University Press (OUP)
- Vol. 25 (15) , 1293-1299
Visualisation and quantification of peri-operative myocardial infarction after coronary artery bypass surgery with contrast-enhanced magnetic resonance imaging
Aims To evaluate if elevated biochemical marker levels after coronary artery bypass grafting (CABG) correspond to the amount of peri-operatively infarcted myocardium, quantified by magnetic resonance imaging (MRI) post-operatively. Methods and results A total of 23 patients without evidence of previous myocardial infarction or myocarditis and with normal pre-operative ECG and left ventricular function and who underwent elective, primary CABG, without any other concomitant cardiac surgery, were included. Plasma creatinine kinase MB (CK-MB) and troponin I and T were measured on the first, second and fourth post-operative days. Between the fourth and ninth post-operative days, cardiac MRI was carried out. Infarctions were found in 18 patients. The infarction mass at MRI was numerically largest in patients with transmural infarctions, all of whom had a CK-MB more than five times the upper normal limit. All three cardiac markers correlated to the mass of infarction. Conclusion Elevated biochemical markers after CABG correspond to the amount of peri-operatively infarcted myocardium.
- 1 August 2004
- Published by Oxford University Press (OUP)
- Vol. 25 (15) , 1293-1299
Open AccessVisualisation and quantification of peri-operative myocardial infarction after coronary artery bypass surgery with contrast-enhanced magnetic resonance imaging
Aims To evaluate if elevated biochemical marker levels after coronary artery bypass grafting (CABG) correspond to the amount of peri-operatively infarcted myocardium, quantified by magnetic resonance imaging (MRI) post-operatively. Methods and results A total of 23 patients without evidence of previous myocardial infarction or myocarditis and with normal pre-operative ECG and left ventricular function and who underwent elective, primary CABG, without any other concomitant cardiac surgery, were included. Plasma creatinine kinase MB (CK-MB) and troponin I and T were measured on the first, second and fourth post-operative days. Between the fourth and ninth post-operative days, cardiac MRI was carried out. Infarctions were found in 18 patients. The infarction mass at MRI was numerically largest in patients with transmural infarctions, all of whom had a CK-MB more than five times the upper normal limit. All three cardiac markers correlated to the mass of infarction. Conclusion Elevated biochemical markers after CABG correspond to the amount of peri-operatively infarcted myocardium.
- 1 August 2004
- Published by Wolters Kluwer Health in Investigative Radiology
- Vol. 39 (8) , 470-478
High In-Plane Resolution T2-Weighted Magnetic Resonance Imaging of Acute Myocardial Ischemia in Pigs Using the Intravascular Contrast Agent NC100150 Injection
The intravascular contrast agent NC100150 injection was tested for its ability to demarcate nonperfused myocardium in a porcine model of coronary occlusion. A T2-weighted fast spin echo sequence was acquired ex vivo and in vivo during first pass and steady-state circulation of the contrast agent in 2 dosages (2 and 5 mg Fe/kg bw) or saline. Ex vivo, in the high-dose group, the volume of nonperfused myocardium determined from T2-weighted images was 99% of that determined from photographs where perfused myocardium stained with fluorescein. A significantly higher contrast to noise ratio between perfused and nonperfused myocardium was found (both ex and in vivo in steady state) compared with the control group. During first pass, a significant reduction in signal intensity (74 +/- 18%) was found in perfused myocardium after contrast injection. NC100150 injection, combined with T2-weighted turbo spin echo imaging, allowed detailed visualization of non-perfused myocardium in the steady state, which corresponded to the area at risk as determined by fluorescein.
- 1 August 2004
- Published by Wolters Kluwer Health in Investigative Radiology
- Vol. 39 (8) , 470-478
High In-Plane Resolution T2-Weighted Magnetic Resonance Imaging of Acute Myocardial Ischemia in Pigs Using the Intravascular Contrast Agent NC100150 Injection
The intravascular contrast agent NC100150 injection was tested for its ability to demarcate nonperfused myocardium in a porcine model of coronary occlusion. A T2-weighted fast spin echo sequence was acquired ex vivo and in vivo during first pass and steady-state circulation of the contrast agent in 2 dosages (2 and 5 mg Fe/kg bw) or saline. Ex vivo, in the high-dose group, the volume of nonperfused myocardium determined from T2-weighted images was 99% of that determined from photographs where perfused myocardium stained with fluorescein. A significantly higher contrast to noise ratio between perfused and nonperfused myocardium was found (both ex and in vivo in steady state) compared with the control group. During first pass, a significant reduction in signal intensity (74 +/- 18%) was found in perfused myocardium after contrast injection. NC100150 injection, combined with T2-weighted turbo spin echo imaging, allowed detailed visualization of non-perfused myocardium in the steady state, which corresponded to the area at risk as determined by fluorescein.
- 1 December 2001
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 221 (3) , 822-826
First-Pass Myocardial Perfusion MR Imaging with Outer-Volume Suppression and the Intravascular Contrast Agent NC100150 Injection: Preliminary Results in Eight Patients
The authors evaluated the feasibility of combining single-shot T2-weighted turbo spin-echo magnetic resonance (MR) imaging and first-pass myocardial perfusion MR imaging with an intravascular ultrasmall superparamagnetic iron oxide (USPIO) contrast agent, NC100150 Injection (3 mg of iron per kilogram of body weight). Eight patients with coronary vessel disease underwent T2-weighted turbo spin-echo MR imaging (in-plane resolution, 1-2 mm) during the first pass of the USPIO contrast agent. The mean decrease in signal intensity in myocardium perfused by a nonstenotic coronary artery was 59% +/- 13 (SD) (P < .012) This method is feasible for imaging of myocardial perfusion.
- 1 December 2001
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 221 (3) , 822-826
First-Pass Myocardial Perfusion MR Imaging with Outer-Volume Suppression and the Intravascular Contrast Agent NC100150 Injection: Preliminary Results in Eight Patients
The authors evaluated the feasibility of combining single-shot T2-weighted turbo spin-echo magnetic resonance (MR) imaging and first-pass myocardial perfusion MR imaging with an intravascular ultrasmall superparamagnetic iron oxide (USPIO) contrast agent, NC100150 Injection (3 mg of iron per kilogram of body weight). Eight patients with coronary vessel disease underwent T2-weighted turbo spin-echo MR imaging (in-plane resolution, 1-2 mm) during the first pass of the USPIO contrast agent. The mean decrease in signal intensity in myocardium perfused by a nonstenotic coronary artery was 59% +/- 13 (SD) (P < .012) This method is feasible for imaging of myocardial perfusion.
- Open Access
- 29 November 2000
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 12 (6) , 866-872
Evaluation of nonperfused myocardial ischemia with MRI and an intravascular USPIO contrast agent in an ex vivo pig model
- 29 November 2000
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 12 (6) , 866-872
Open AccessEvaluation of nonperfused myocardial ischemia with MRI and an intravascular USPIO contrast agent in an ex vivo pig model